Westwood Holdings Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,329,787
Closed -$62.5M 491
2025
Q3
$62.5M Buy
1,329,787
+92,536
+7% +$4.8M 0.45% 96
2025
Q2
$64.4M Sell
1,237,251
-484
-0% -$26.6K 0.46% 91
2025
Q1
$74.7M Buy
1,237,735
+360,336
+41% +$23.2M 0.56% 66
2024
Q4
$60M Sell
877,399
-4,708
-0.5% -$328K 0.46% 82
2024
Q3
$63.4M Buy
882,107
+33,442
+4% +$2.36M 0.27% 125
2024
Q2
$58.8M Buy
848,665
+9,676
+1% +$706K 0.27% 126
2024
Q1
$67.2M Buy
838,989
+270,297
+48% +$24.1M 0.53% 76
2023
Q4
$62.3M Buy
568,692
+9,535
+2% +$986K 0.53% 87
2023
Q3
$56.4M Buy
559,157
+111,466
+25% +$12.8M 0.53% 83
2023
Q2
$60.8M Sell
447,691
-120,062
-21% -$14.7M 0.54% 82
2023
Q1
$59M Sell
567,753
-51,047
-8% -$4.94M 0.53% 82
2022
Q4
$54.9M Buy
618,800
+4,518
+0.7% +$375K 0.48% 95
2022
Q3
$49.2M Buy
614,282
+89,975
+17% +$8.49M 0.58% 81
2022
Q2
$50.2M Buy
524,307
+119,633
+30% +$14.4M 0.55% 83
2022
Q1
$60.1M Sell
404,674
-23,792
-6% -$3.32M 0.56% 77
2021
Q4
$60.7M Buy
428,466
+35,795
+9% +$5.07M 0.55% 83
2021
Q3
$51.4M Sell
392,671
-3,892
-1% -$509K 0.56% 68
2021
Q2
$54.5M Buy
396,563
+23,642
+6% +$3.24M 0.55% 71
2021
Q1
$48.7M Buy
372,921
+27,458
+8% +$3.3M 0.49% 79
2020
Q4
$38.7M Sell
345,463
-13,063
-4% -$1.24M 0.45% 74
2020
Q3
$28.2M Sell
358,526
-6,082
-2% -$496K 0.36% 94
2020
Q2
$26.2M Buy
364,608
+2,421
+0.7% +$168K 0.35% 98
2020
Q1
$20.7M Buy
362,187
+87,609
+32% +$8.08M 0.31% 101
2019
Q4
$30.7M Sell
274,578
-6,882
-2% -$733K 0.33% 95
2019
Q3
$27.1M Sell
281,460
-72,787
-21% -$6.83M 0.3% 103
2019
Q2
$30.3M Sell
354,247
-40,732
-10% -$3.35M 0.33% 93
2019
Q1
$32.9M Buy
394,979
+3,192
+0.8% +$232K 0.34% 91
2018
Q4
$25.2M Buy
391,787
+107,464
+38% +$7.35M 0.29% 92
2018
Q3
$22.5M Sell
284,323
-15,938
-5% -$1.23M 0.2% 140
2018
Q2
$22M Sell
300,261
-31,030
-9% -$2.11M 0.18% 156
2018
Q1
$21M Sell
331,291
-37,454
-10% -$2.24M 0.17% 161
2017
Q4
$18.8M Buy
368,745
+21,800
+6% +$1.14M 0.14% 164
2017
Q3
$18.2M Buy
346,945
+70,306
+25% +$3.53M 0.14% 162
2017
Q2
$14.1M Buy
276,639
+44,723
+19% +$2.21M 0.11% 169
2017
Q1
$10.3M Sell
231,916
-19,315
-8% -$831K 0.08% 191
2016
Q4
$11.1M Sell
251,231
-242,304
-49% -$10.3M 0.09% 179
2016
Q3
$19.8M Sell
493,535
-428,505
-46% -$18.2M 0.17% 137
2016
Q2
$44M Sell
922,040
-104,336
-10% -$4.42M 0.39% 97
2016
Q1
$43M Buy
1,026,376
+89,861
+10% +$3.53M 0.37% 97
2015
Q4
$41.3M Buy
936,515
+118,266
+14% +$5.13M 0.36% 100
2015
Q3
$39.1M Buy
818,249
+33,890
+4% +$1.86M 0.34% 104
2015
Q2
$45.7M Sell
784,359
-513,827
-40% -$27.7M 0.34% 116
2015
Q1
$65.5M Buy
1,298,186
+892,436
+220% +$43.7M 0.5% 83
2014
Q4
$18.2M Buy
+405,750
New +$17M 0.14% 146

Other funds holding CNMD

Westwood Holdings Group's CNMD Position: Q4 2025 in Review

Westwood Holdings Group sold out of CONMED (CNMD) in Q4 2025, closing a stake of 1,329,787 shares — an estimated $62.5M sold.

Westwood Holdings Group first reported a position in CNMD in Q4 2014 and held it in 44 quarters. The position peaked at $74.7M in Q1 2025. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • Westwood Holdings Group reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • Westwood Holdings Group sold 1,329,787 CONMED shares in Q4 2025, an estimated $62.5M.
  • Westwood Holdings Group first reported a position in CONMED in Q4 2014 and held it in 44 quarters.
  • Westwood Holdings Group's CONMED position peaked at $74.7M in Q1 2025.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Westwood Holdings Group's 13F filing for Q4 2025, filed 17 Feb 2026.